Cloud DX Announces Initial Closing of Brokered Private Placement
KITCHNER, ON / ACCESSWIRE / January 27, 2022 / Cloud DX Inc. ("Cloud" or the "Corporation") (TSXV:CDX)(OTCQB:CDXFF), a leading North...
Month: January 2022
Radicle Health Acquires Stabilify, Joining Forces With KCare Further Expanding in the Child Welfare Software Market
NEW YORK & MIAMI & AUSTIN, Texas--(BUSINESS WIRE)--Radicle Health, a human services software organization, today announced that it has acquired...
Digital Health Tech Turns to Wolters Kluwer for Trusted Consumer Content & Decision Support
Digital Health Architect platform helps healthcare organizations and virtual care vendors integrate evidence-based content from UpToDate, Emmi and Lexicomp for...
Poko Group Innovations, Inc. Releases Year-End 2021 Letter to Shareholders
Company Anticipates a Successful 2022LONDON, UK and BELFAST, UK / ACCESSWIRE / January 27, 2022 / (CSE:POKO) - Poko Innovations,...
Imaging Biometrics LLC – Letter to Shareholders
Imaging Biometrics, a subsidiary of IQ-AI Limited (OTCQB:IQAIF) (LSE:IQAI), discusses its most successful year on record.Increases technology platform and expects...
Dynatronics Corporation Schedules Conference Call and Webcast to Provide Business Update and Discuss Second Quarter of Fiscal Year 2022 Results
EAGAN, MN / ACCESSWIRE / January 27, 2022 / Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy,...
IAVI and Moderna Launch Trial of HIV Vaccine Antigens Delivered Through mRNA Technology
Phase 1 trial aims to build on response seen in proof-of-concept trialCAMBRIDGE, MA and NEW YORK, NY / ACCESSWIRE /...
Panacea Life Sciences’ New CBDA Oil Drops are Now Available for Purchase Online at panacealife.com
GOLDEN, CO / ACCESSWIRE / January 27, 2022 / Panacea Life Sciences Holdings, Inc. (OTCQB:PLSH) ("Panacea" or the "Company"), a...
Pressure BioSciences Ultra Shear Technology Commercialization Achieves Key Milestone: Production-Scale System Commissioned at Ohio State to Serve Food Industry
Installation of BaroShear MAX UST System in Acclaimed The Ohio State University Food Pilot Plant Will Introduce Global Food Industry...
Mirror Biologics Appoints Joel Kanter as Chairman of the Board of Directors
Adi Raviv Continues as Chief Executive Officer and PresidentLUTZ, FL / ACCESSWIRE / January 27, 2022 / Mirror Biologics, Inc....
Castellum, Inc. Announces Q4 Record Revenue
Castellum, Inc. Announces Q4 Record Revenue Castellum, Inc. (OTC: ONOV) announces that it generated approximately $9.5 million in unaudited revenue...
Sugarlogix Announces Relaunch as NAMUH
Company Will Close Nutritional Gap Between Infant Formula and Human MilkALAMEDA, Calif., Jan. 27, 2022 (GLOBE NEWSWIRE) -- Sugarlogix, a...
Simcha Therapeutics Raises $40 Million Series B Financing and Initiates Phase 1/2 Study to Evaluate Novel Interleukin-18 Variant in Cancer
Financing led by SR One; Proceeds to advance proprietary IL-18 variant through Phase 2 clinical trial ST-067 is a first-in-class...
Trevena Announces Submission of New Drug Application in China for OLINVYK® by its Partner Jiangsu Nhwa Pharmaceutical
Submission supported by data from a Phase 3 bridging study of oliceridine injection compared to IV morphine, conducted in China...
SmileDirectClub Advances Whitening Portfolio with Launch of Wireless Pro Whitening System Plus
Latest Advancement in Oral Care Increases Access to Innovative Teeth Whitening for a Brighter, Healthier Smile SmileDirectClub Pro Whitening System...
Option Care Health to Announce Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call
BANNOCKBURN, Ill., Jan. 27, 2022 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest...
Assure Sets Managed Cases Record for Full-Year, Fourth Quarter and Month of December 2021
DENVER, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM; TSXV: IOM), a provider...
Acer Therapeutics and Relief Therapeutics Announce Presentation of Four ACER-001 Posters at the Upcoming SIMD and GMDI Conferences
Data to be presented suggests ACER-001 could represent a potential alternative to sodium and glycerol phenylbutyrate for treatment of UCDsNEWTON,...
Ensysce Biosciences Announces Results of Special Meeting of Stockholders
SAN DIEGO, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) (NASDAQ: ENSC, OTC: ENSCW), a...
Todos Medical and NLC Pharma Announce Primary and Secondary Endpoints Met in NLC-V-01 Phase 2 Clinical Trial of Oral Antiviral 3CL Protease Inhibitor Tollovir™ in the Treatment of Hospitalized COVID-19 Patients
§ Phase 2 Study NLC-V-01 closed early after interim data analysis due to positive clinical efficacy § Primary endpoint of...